Award Recipient 2026
Laura Cendron
Department of Biology, University of Padova
Padua, Italy.
Project: ALBATROS: ALBumin-assisted long-acting peptide therapeutics for rheumatoid arthritis
Padua, Italy.
Project: ALBATROS: ALBumin-assisted long-acting peptide therapeutics for rheumatoid arthritis
Award Recipient 2025
Inés Moreno González
Department of Cell Biology of the University of Malaga
Malaga, Spain.
Project: Uncovering Albumin’s Therapeutic Potential to Modulate Tau Pathology by Blood Exchange
Malaga, Spain.
Project: Uncovering Albumin’s Therapeutic Potential to Modulate Tau Pathology by Blood Exchange
Award Recipient 2024
Bryce A. Kerlin, MD
The Abigail Wexner Research Institute at Nationwide Children’s Hospital
Ohio, USA.
Project: Albumin-Dependent Endothelial Cytoprotection
Ohio, USA.
Project: Albumin-Dependent Endothelial Cytoprotection
Award Recipients 2023
Robert Hahn, MD, PhD
Karolinska Institute, Danderyds Hospital
Stockholm, Sweden
Project: 5% and 20% albumin vs Ringer for goal-directed fluid therapy in major surgery
Stockholm, Sweden
Project: 5% and 20% albumin vs Ringer for goal-directed fluid therapy in major surgery
Alessandra Di Masi, PhD
Department of Science, Section of Biomedical Sciences and Technologies
Roma Tre University
Rome, Italy
Roma Tre University
Rome, Italy
Project: Dissecting the role of human serum albumin in the innate immunity response
Award Recipients 2022
Margret Paar, PhD
Division of Medicinal Chemistry, Otto-Loewi Research Center
Medical University of Graz
Graz, Austria
Project: What makes Albumin (in)effective?
Medical University of Graz
Graz, Austria
Project: What makes Albumin (in)effective?
Mattia Busana, MD
Department of Anesthesiology and Intensive Care
University Medical Center Göttingen
Göttingen, Germany
University Medical Center Göttingen
Göttingen, Germany
Project: Lung edema and VILI development: does the fluid type matter?
Award Recipients 2021
Christoph R. Behem, MD
Department of Anesthesiology, Center of Anesthesiology and Intensive Care Medicine
University Medical Center Hamburg-Eppendorf
Hamburg, Germany
Project: The use of Albumin for optimization of spinal cord microcirculatory blood‐flow and oxygenation in an experimental model of spinal cord ischemia.
University Medical Center Hamburg-Eppendorf
Hamburg, Germany
Project: The use of Albumin for optimization of spinal cord microcirculatory blood‐flow and oxygenation in an experimental model of spinal cord ischemia.
Martin Sebastian Winkler, MD
Department of Anesthesiology and Intensive Care
University Medicine Goettingen
Goettingen, Germany
University Medicine Goettingen
Goettingen, Germany
Project: Non-oncotic effects of albumin as a carrier of sphingosine-1-phosphate for the restoration of endothelial cell barriers and immune cell function in sepsis.
Publication: The potential effect of albumin replacement on immune modulation and sphingosine 1-phosphate dynamics.
Award Recipients 2020
Mar Hernández, PhD
Vall d'Hebron Research Institute
Hospital Vall d'Hebron
Barcelona, Spain
Project: Nanotechnology albumin-based approach for the diagnosis and treatment of Alzheimer's Disease
Hospital Vall d'Hebron
Barcelona, Spain
Project: Nanotechnology albumin-based approach for the diagnosis and treatment of Alzheimer's Disease
Hafid Ait-Oufella, MD, PhD
Division of Intensive Care Medicine
St-Antoine Hospital
Paris, France
St-Antoine Hospital
Paris, France
Project: Impact of albumin infusion on tissue perfusion in septic shock patients. A prospective pathophysiological study
Award Recipients 2019
Prof. Davide Chiumello
Direttore SC Anestesia e Rianimazione
Ospedale San Paolo – Polo Universitario, ASST Santi Paolo e Carlo
Milan, Italy
Project: Effect of volume EXpansion witH ALbumin vs. crystalloid on EIT-derived expiratory lung impedance in critically ill, hemodynamically unstable patients. A single-blind, randomized and controlled study (the EXHALE study)
Ospedale San Paolo – Polo Universitario, ASST Santi Paolo e Carlo
Milan, Italy
Project: Effect of volume EXpansion witH ALbumin vs. crystalloid on EIT-derived expiratory lung impedance in critically ill, hemodynamically unstable patients. A single-blind, randomized and controlled study (the EXHALE study)
Aurora Pujol, MD, PhD
Neurometabolic Diseases Laboratory
Bellvitge Biomedical Research Institute IDIBELL- Hospital Duran i Reynals
Barcelona, Spain
Bellvitge Biomedical Research Institute IDIBELL- Hospital Duran i Reynals
Barcelona, Spain
Project: Human albumin in plasma exchange as a novel approach for adrenoleukodystrophy
Award Recipients 2018
Paolo Caraceni, MD
Department of Medical and Surgical Sciences
Alma Mater Studiorum University of Bologna
Bologna, Italy
Project: Long‐term albumin administration in patients with decompensated cirrhosis: clinical and pathophysiological implications
Alma Mater Studiorum University of Bologna
Bologna, Italy
Project: Long‐term albumin administration in patients with decompensated cirrhosis: clinical and pathophysiological implications
Hanadi Sleiman, PhD
Department of Chemistry
McGill University
Montreal, Canada
Montreal, Canada
Project: Albumin as a passive targeting agent: effect of the protein binding on stability, bio distribution and therapeutic outcome of oligonucleotides and DNA nanoparticles
Award Recipients 2017
Anna ROIG, PhD
Institut de Ciència de Materials de Barcelona
Consejo Superior de Investigaciones Científicas
Bellaterra (Barcelona), Spain
Project: Albumin-iron oxide nanocages
Consejo Superior de Investigaciones Científicas
Bellaterra (Barcelona), Spain
Project: Albumin-iron oxide nanocages
Karl OETTL, PhD
Institute of Physiological Chemistry
Medical University of Graz
Graz, Austria
Graz, Austria
Project: Effect of albumin redox state on the intracellular redox balance in cell culture
Publication: Albumin in patients with liver disease shows an altered conformation - PubMed (nih.gov)
Award Recipients 2016
Joan CLÀRIA, Bsc, PhD
Hospital Clínic
Faculty of Medicine, University of Barcelona
Barcelona, Spain
Project: Effects of native (reduced) and oxidized albumin forms on human leukocyte function
Faculty of Medicine, University of Barcelona
Barcelona, Spain
Project: Effects of native (reduced) and oxidized albumin forms on human leukocyte function
Rudolf E. STAUBER, MD
Division of Gastroenterology and Hepatology
Department of Internal Medicine, Medical University of Graz
Graz, Austria
Graz, Austria
Project: Effect of albumin infusion on oxidative albumin modification and albumin binding capacity
Publication: Effect of albumin infusion on oxidative albumin modification and albumin binding capacity in chronic liver failure
Award Recipients 2015
Pietro CAIRONI, MD
Department of Pathophysiology and Transplantation
Fondazione IRCCS Ca' Granda – Ospedale Maggiore Policlinico, University of Milan
Milan, Italy
Project: Albumin administration as a therapeutic approach to attenuate sepsis-induced glycocalyx disruption in human septic shock
Fondazione IRCCS Ca' Granda – Ospedale Maggiore Policlinico, University of Milan
Milan, Italy
Project: Albumin administration as a therapeutic approach to attenuate sepsis-induced glycocalyx disruption in human septic shock
James RUSSELL, MD
University of British Columbia
Principal Investigator
Centre for Heart Lung Innovation, St. Paul's Hospital
Vancouver, BC, Canada
Principal Investigator
Centre for Heart Lung Innovation, St. Paul's Hospital
Vancouver, BC, Canada
Project: Is heparin-binding protein a mechanism of Albumin's efficacy in human septic shock?
Publication: Is Heparin-Binding Protein Inhibition a Mechanism of Albumin's Efficacy in Human Septic Shock? - PubMed (nih.gov)